Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Walkaway systems in general practice: Behring ELISA Processor III]

G Lanzer1, J Beyer, D Weisshaar

  • 1Blutspendedienst Graz, Osterreich.

Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collapse of Nuclear Collectivity along the N=Z Line.

Physical review letters·2026
Same author

Clarifying the N,Z=14 Shells near the Drip Lines from the Spectroscopy of ^{22}Si and ^{21}Al.

Physical review letters·2026
Same author

Abrupt structural transition in exotic molybdenum isotopes unveils an isospin-symmetric island of inversion.

Nature communications·2025
Same author

Observation of New Isotopes in the Fragmentation of ^{198}Pt at FRIB.

Physical review letters·2024
Same author

Dissipative Reactions with Intermediate-Energy Beams: A Novel Approach to Populate Complex-Structure States in Rare Isotopes.

Physical review letters·2022
Same author

New ^{59}Fe Stellar Decay Rate with Implications for the ^{60}Fe Radioactivity in Massive Stars.

Physical review letters·2021
Same journal

[Not Available].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Preliminary results of the 2nd multicenter study. Thrombocytapheresis with the Fresenius AS-104 blood cell separator and ring study of cell counting. Section of Therapeutic and Preparative Hemapheresis of the DGTI].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Thrombocyte substitution in hematologic patients].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Substitution of thrombocyte concentrates in polytransfused patients].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Indications for fresh frozen plasma: evaluation of virus inactivating preparations].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Indications for irradiated blood components: dose and side effects].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
See all related articles

The Behring Elisa Processor III is a reliable automated system for blood transfusion services. This Walkaway instrument enhances efficiency and security in testing for HBsAG, anti-HCV, and anti-HIV 1/2.

Area of Science:

  • Clinical diagnostics
  • Transfusion medicine
  • Laboratory automation

Context:

  • Blood transfusion services require efficient and secure methods for infectious disease screening.
  • High-throughput testing for HBsAG, anti-HCV, and anti-HIV 1/2 is critical for blood safety.
  • Evaluating new automated systems is essential for optimizing laboratory workflows.

Purpose:

  • To evaluate the performance of the Behring Elisa Processor III (Walkaway instrument) in routine blood transfusion settings.
  • To assess the instrument's ability to handle varying sample volumes (60,000 to 450,000 per year).
  • To determine the impact of the instrument on labor, security, and laboratory organization.

Summary:

  • The Behring Elisa Processor III demonstrated effectiveness as a Walkaway system in three blood transfusion services.

Related Experiment Videos

  • The instrument successfully reduced labor requirements and increased testing security.
  • Compliance with Good Laboratory Practice (GLP) rules and documentation of test steps were confirmed.

    • Impact:

    • Implementation of the Walkaway instrument streamlines laboratory operations.
    • Increased transparency and improved workflow management in transfusion diagnostics.
    • Enhanced blood safety through reliable and automated infectious disease screening.